FDA Food recall F-1371-2014
USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the…
- FDA Food
- Class I
- terminated
- Published 2014-01-22
On 2014-01-22 the FDA classified a Class I recall of USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the… by Usplabs, citing USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serio….
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-1371-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-11-09 |
| Published | 2014-01-22 |
| Last updated | 2026-09-13 11:48 UTC |
| Company | Usplabs |
| Distribution | n/a |
Product
USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the following sizes: 3 count; 90 count; and 180 count.
Reason
USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serious adverse health events, namely serious liver damage or acute liver failure.
Identifiers
| upc | 094922447883 |
|---|---|
| upc | 094922447876 |
| upc | 094922395627 |
| upc | 094922447869 |
| code_info | 3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:48 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1371-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.